Literature DB >> 23360796

Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer.

Devyani Samantarrai1, Subhra Dash, Bini Chhetri, Bibekanand Mallick.   

Abstract

MicroRNAs (miRNA) are a class of endogenous, small noncoding RNAs found in animals, plants, and viruses that control their target gene expression posttranscriptionally. They are involved in a wide array of biological processes including cell differentiation, development, cell death and homeostasis, and fine-tune the regulation of these pathways. Their aberrant expressions have been associated with different diseases. These small RNAs are also known to function as oncogenes, oncosupressor genes, modulators of metastatic spread, and regulators of cancer stem cells. Their deregulation is a hallmark of different cancers types including breast cancer. Despite the growing evidence for their involvement in breast cancer, understanding the interplay between miRNAs and their targets leading to the disease remains largely unknown. Here, we provide a comprehensive story on miRNA signatures of breast cancer, miRNAs in breast cancer stem cells, metastamirs (i.e., metastasis regulatory miRNAs), circulating miRNAs as invasive blood-based biomarkers, and oncomiRs and oncosupressor miRNAs associated with breast cancer. Furthermore, we provide biological insights on their regulation by various mechanisms including genomic alterations and demonstration of a complicated feedback network between miRNAs and epigenetic regulators forming an epigenetics-miRNA regulatory circuit whose disruption may underlie the cause of breast cancer. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360796     DOI: 10.1158/1541-7786.MCR-12-0649

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  16 in total

1.  Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.

Authors:  Edward A Ratovitski
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

2.  Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC.

Authors:  Ziqiang Tian; Zhenhua Li; Yonggang Zhu; Lingjiao Meng; Fei Liu; Meixiang Sang; Guiying Wang
Journal:  Clin Exp Metastasis       Date:  2019-06-13       Impact factor: 5.150

Review 3.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

4.  microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.

Authors:  Chin-Wen Chang; Hui-Chen Wu; Mary Beth Terry; Regina M Santella
Journal:  Anticancer Res       Date:  2015-07       Impact factor: 2.480

5.  Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation.

Authors:  Valeria Canu; Sara Donzelli; Andrea Sacconi; Federica Lo Sardo; Claudio Pulito; Noa Bossel; Anna Di Benedetto; Paola Muti; Claudio Botti; Eytan Domany; Silvio Bicciato; Sabrina Strano; Yosef Yarden; Giovanni Blandino
Journal:  Cell Death Differ       Date:  2020-11-23       Impact factor: 15.828

6.  Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma.

Authors:  Devyani Samantarrai; Mousumi Sahu; Jyoti Roy; Bedanta Ballav Mohanty; Garima Singh; Chandra Bhushan; Bibekanand Mallick
Journal:  Sci Rep       Date:  2015-05-18       Impact factor: 4.379

Review 7.  Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  BMC Syst Biol       Date:  2015-09-21

Review 8.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.

Authors:  Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2015-02-03       Impact factor: 4.102

9.  Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit.

Authors:  Xiuming Liang; Jiping Zeng; Lixiang Wang; Li Shen; Xueping Ma; Shuyan Li; Yujiao Wu; Lin Ma; Xinyu Ci; Qing Guo; Mutian Jia; Haiyu Shen; Yundong Sun; Zhifang Liu; Shili Liu; Wenjuan Li; Han Yu; Chunyan Chen; Jihui Jia
Journal:  Oncotarget       Date:  2015-07-10

10.  miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.

Authors:  Shoko Vos; Farhad Vesuna; Venu Raman; Paul J van Diest; Petra van der Groep
Journal:  Oncotarget       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.